AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service
Karachi: GlaxoSmithKline Pakistan Limited has scheduled a Board of Directors meeting on July 30, 2024, to address items other than financial results.
The company has initiated a “Closed Period” from July 24 to July 30, during which no director, CEO, or executive is permitted to trade company shares. This measure complies with Clause 5.6.1(d) of the Pakistan Stock Exchange Regulations. Certificate holders of the exchange have been notified about these developments.
According to information available from the Pakistan Stock Exchange (PSX), these corporate governance practices are designed to prevent any insider trading or conflicts of interest during pivotal board deliberations.